Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	24.81B +18.3%
Revenue (ttm)	8.55B -9.2%
Net Income	373.17M -67.4%
EPS	0.25 -68.5%
Shares Out	1.49B
PE Ratio	92.50
Forward PE	34.87
Dividend	0.10 (0.60%)
Ex-Dividend Date	Jul 10, 2025

Volume	64,149,428
Average Volume	27,524,426
Open	16.61
Previous Close	16.65
Day's Range	16.61 - 17.65
52-Week Range	14.37 - 27.97
Beta	0.18
RSI	58.34
Earnings Date	Apr 30, 2026

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade serv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2025, SHA:600521's revenue was 8.59 billion, a decrease of -10.06% compared to the previous year's 9.55 billion. Earnings were 266.40 million, a decrease of -76.19%.